What Is Entresto and Why Dose Matters
Entresto is a prescription combination medication used to treat heart failure in adults. It contains sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker. Because Entresto affects blood pressure and kidney function, starting doses and adjustments must be carefully managed. This guide explains typical dosing patterns, how strength choices are determined, and key safety points. The information here supports shared decision-making with clinicians and helps patients understand what to expect during treatment.
Standard Starting Dose by Heart Failure Type
Doctors typically begin Entresto at a low dose to reduce the risk of low blood pressure, especially when initiating therapy or switching from another heart failure medicine. The standard starting approach depends on the type of heart failure and whether the patient is new to sacubitril/valsartan or converting from an ACE inhibitor.
- For heart failure with reduced ejection fraction (HFrEF): The usual starting dose is 49 mg/51 mg (24 mg sacubitril/25 mg valsartan) twice daily.
- For heart failure with preserved ejection fraction (HFpEF): Dosing follows the same initial approach as HFrEF in many cases, but clinicians tailor targets to Blood Pressure and kidney metrics.
Typical Maintenance Range
After safely reaching the starting dose, the target maintenance dose is often 196 mg/204 mg (97 mg sacubitril/102 mg valsartan) twice daily, which is the higher strength approved for this indication. Some people may remain on a lower maintenance level if higher doses are not tolerated. Doses are usually taken about 12 hours apart, with or without food.
Conversion Rules From an ACE Inhibitor
- Stop the ACE inhibitor and wait at least 36 hours before starting Entresto.
- The first Entresto dose is typically lower to prevent a sudden drop in blood pressure.
How the 100 mg and 200 mg Labels Are Used
In some regions, Entresto may be referred to using combined strengths such as 100 mg or 200 mg for simplicity in conversation, but the actual approved dosing is expressed as sacubitril/valsartan amounts. It is important to confirm the exact component strengths on the prescription label to match the clinician’s instructions.
Dose Adjustment Factors
Clinicians consider several personal factors when choosing and changing Entresto doses. Age, kidney function, blood pressure, and other medications can all influence how quickly and how high the dose can be increased.
| Factor | Impact on Dosing | Source Type |
|---|---|---|
| Kidney Function (eGFR) | May require slower titration or lower doses if reduced | Label Guidance |
| Blood Pressure | Lower starting dose and slower increases if systolic BP is low | Label Guidance |
| Body Weight or frailty | May influence choice of starting dose in older adults | Clinical Practice |
| Concomitant medications | Avoid concurrent ACE inhibitor use and monitor with certain diuretics | Label Guidance |
Practical Dosing Schedule Examples
Below are simplified examples to illustrate how doses may be structured in everyday practice. Individual plans will vary based on medical history and response. These schedules are not a substitute for personalized instructions from a clinician.
| Example | Starting Regimen | Target Maintenance Regimen |
|---|---|---|
| Adult with HFrEF | 49 mg/51 mg twice daily | 196 mg/204 mg twice daily |
| Adult converted from ACE inhibitor | Lower initial dose, often 24 mg/26 mg twice daily | Titrated to 97 mg/102 mg twice daily if tolerated |
| Adult with low baseline blood pressure | Smaller increments and longer monitoring between changes | Dose kept at the best tolerated level |
Safety Considerations and When to Contact a Clinician
While many people tolerate Entresto well, some side effects and interactions require prompt attention. Low blood pressure, worsening kidney function, and high potassium levels are potential concerns. Patients should seek medical care for symptoms such as lightheadedness, fainting, sudden swelling, or shortness of breath that worsens after dose changes.
- Do not take Entresto if you are pregnant or planning to become pregnant.
- Avoid abrupt discontinuation without clinician guidance.
- Inform the care team about all prescription and over-the-counter medicines, including herbal supplements.
Key Takeaways
Entresto dosing is individualized based on heart failure type, kidney function, blood pressure, and concurrent medications. Most adults start at 49 mg/51 mg twice daily and may be titrated toward 196 mg/204 mg twice daily when appropriate. A cautious, monitored transition from ACE inhibitors is standard. Regular follow-up and lab monitoring help ensure that the chosen dose remains safe and effective over time.